InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-8.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Knutson Gregory, Director. Director active across 1 company, notably U.S. Stem Cell, Inc.. Cumulatively, 4 disclosures have been logged. History available since 1 April 2020. The latest transaction was disclosed on 25 April 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
2,500,000 shares@ US$0.00414.55% mcap4.5% of flowCommon StockSEC:0001185185-22-000518:0
25,000,000 shares@ US$0.00887.7% of flowCommon StockSEC:0001185185-22-000329:0
1,445,647 shares@ US$0.0063.9% of flowCommon StockSEC:0001185185-21-001026
1,445,647 shares@ US$0.00612.34% mcap3.9% of flowCommon StockSEC:0001185185-21-001026:0
4 of 4 declarations
About Knutson Gregory
Knutson Gregory is a Director at U.S. Stem Cell, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable strategic insights. Gregory is committed to supporting the company's mission and fostering its growth.
